InvestorsHub Logo
Followers 61
Posts 7519
Boards Moderated 2
Alias Born 02/10/2010

Re: jdheart101 post# 43587

Friday, 11/17/2023 8:38:46 AM

Friday, November 17, 2023 8:38:46 AM

Post# of 43716

They just killed the company for the next 6 months

LOL - You chose to miss the point.

They received $5MM in operating funds. That is the only relevant point for a pre-revenue biopharma company. Their market cap would be an irrelevant point for the next 6 months if they didn't have the operating capital to keep operating in the near term.

Their relatively small dilution this week did not do a thing to my actual cost per share, other than let me buy some more shares at about $2.30 yesterday and lower my dollar cost average some more. Nor does their relatively small dilution this week change what those shares could be worth when Multikine gets approval in one (or more) of the EU, Canada, Great Britain, or with the FDA.

“The two most powerful warriors are patience and time.”
- Leo Nikolaevich Tolstoy

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News